Tissue resident iNKT17 cells facilitate cancer cell extravasation in liver metastasis via interleukin-22.
ANPEP
IL-22
cancer cell extravasation
endothelial cells
extravasation
metastasis
metastasis formation
tissue resident cells
Journal
Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918
Informations de publication
Date de publication:
10 01 2023
10 01 2023
Historique:
received:
22
08
2022
revised:
09
09
2022
accepted:
14
12
2022
entrez:
11
1
2023
pubmed:
12
1
2023
medline:
14
1
2023
Statut:
ppublish
Résumé
During metastasis, cancer cells invade, intravasate, enter the circulation, extravasate, and colonize target organs. Here, we examined the role of interleukin (IL)-22 in metastasis. Immune cell-derived IL-22 acts on epithelial tissues, promoting regeneration and healing upon tissue damage, but it is also associated with malignancy. Il22-deficient mice and mice treated with an IL-22 antibody were protected from colon-cancer-derived liver and lung metastasis formation, while overexpression of IL-22 promoted metastasis. Mechanistically, IL-22 acted on endothelial cells, promoting endothelial permeability and cancer cell transmigration via induction of endothelial aminopeptidase N. Multi-parameter flow cytometry and single-cell sequencing of immune cells isolated during cancer cell extravasation into the liver revealed iNKT17 cells as source of IL-22. iNKT-cell-deficient mice exhibited reduced metastases, which was reversed by injection of wild type, but not Il22-deficient, invariant natural killer T (iNKT) cells. IL-22-producing iNKT cells promoting metastasis were tissue resident, as demonstrated by parabiosis. Thus, IL-22 may present a therapeutic target for prevention of metastasis.
Identifiants
pubmed: 36630911
pii: S1074-7613(22)00650-1
doi: 10.1016/j.immuni.2022.12.014
pmc: PMC9839362
pii:
doi:
Substances chimiques
Interleukins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
125-142.e12Subventions
Organisme : Howard Hughes Medical Institute
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests S.K. declares honoraria from GSK, BMS, Novartis, and TCR2, Inc.; license fees from TCR2, Inc. and Carina Biotech; and research support from TCR2, Inc., Plectonic GmbH, Tabby Therapeutics, and Arcus Biosciences.
Références
PLoS Biol. 2005 Apr;3(4):e113
pubmed: 15799695
Cell Immunol. 2009;254(2):81-4
pubmed: 19010461
J Thorac Cardiovasc Surg. 2009 Feb;137(2):486-91
pubmed: 19185174
Mol Ther. 2008 Apr;16(4):698-706
pubmed: 18362927
Mol Cancer. 2014 Nov 05;13:244
pubmed: 25373310
Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1637-42
pubmed: 22307623
J Clin Invest. 2009 Dec;119(12):3573-85
pubmed: 19920355
J Clin Invest. 2015 Dec;125(12):4529-43
pubmed: 26571401
Circulation. 2020 Nov 10;142(19):1848-1862
pubmed: 32929989
Histochem Cell Biol. 2011 May;135(5):499-512
pubmed: 21544708
Nat Commun. 2020 Sep 8;11(1):4457
pubmed: 32901017
Nat Commun. 2020 May 25;11(1):2608
pubmed: 32451418
Science. 2018 May 25;360(6391):
pubmed: 29798856
Sci Rep. 2016 Mar 24;6:23682
pubmed: 27009467
Mucosal Immunol. 2018 Jan;11(1):131-143
pubmed: 28401935
Cancer Res. 2018 Jun 15;78(12):3220-3232
pubmed: 29674477
J Am Acad Dermatol. 2018 May;78(5):872-881.e6
pubmed: 29353025
Cancer Med. 2020 Jan;9(1):361-373
pubmed: 31693304
Front Immunol. 2019 Jun 06;10:1126
pubmed: 31244823
J Immunol. 2014 Sep 1;193(5):2512-8
pubmed: 25063867
Nat Biotechnol. 2014 Apr;32(4):364-72
pubmed: 24633240
Front Oncol. 2019 Oct 04;9:1002
pubmed: 31637216
Science. 2016 Oct 21;354(6310):358-362
pubmed: 27846573
Clin Cancer Res. 2020 Aug 15;26(16):4313-4325
pubmed: 32430479
Nature. 2015 Dec 24;528(7583):560-564
pubmed: 26649819
Nat Immunol. 2010 Mar;11(3):197-206
pubmed: 20139988
Nat Med. 2018 Jul;24(7):986-993
pubmed: 29942092
Cell. 2019 Aug 22;178(5):1176-1188.e15
pubmed: 31442406
J Exp Med. 2011 Jun 6;208(6):1179-88
pubmed: 21624939
J Exp Med. 2011 May 9;208(5):1027-40
pubmed: 21518800
Cancer Immunol Res. 2018 Jul;6(7):788-797
pubmed: 29764837
BMC Cancer. 2013 Feb 05;13:59
pubmed: 23379788
Genome Biol. 2019 Dec 23;20(1):296
pubmed: 31870423
Dev Dyn. 2006 Mar;235(3):759-67
pubmed: 16450386
Immunol Rev. 2013 Mar;252(1):116-32
pubmed: 23405899
Gastroenterology. 2017 Mar;152(4):867-879
pubmed: 27889570
Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1565-70
pubmed: 20080688
Biomed Pharmacother. 2018 Jul;103:1101-1106
pubmed: 29710675
Nature. 2019 Feb;566(7743):249-253
pubmed: 30700914
Annu Rev Immunol. 2014;32:323-66
pubmed: 24499274
Nature. 2012 Nov 8;491(7423):259-63
pubmed: 23075849
Nat Immunol. 2005 Sep;6(9):895-901
pubmed: 16116469
PLoS One. 2014 Sep 16;9(9):e106921
pubmed: 25226518
J Clin Invest. 2017 Nov 1;127(11):4031-4041
pubmed: 28945199
Immunity. 2014 May 15;40(5):772-784
pubmed: 24816405
J Exp Med. 2019 Jan 7;216(1):133-151
pubmed: 30518599
J Cell Sci. 2010 Jul 1;123(Pt 13):2332-41
pubmed: 20530574
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Ann Surg Oncol. 2014 Jan;21(1):125-32
pubmed: 24132627
Nat Rev Immunol. 2020 Aug;20(8):483-497
pubmed: 32024984
Immunity. 2016 Mar 15;44(3):698-711
pubmed: 26982367
Carcinogenesis. 2010 May;31(5):946-52
pubmed: 20176656
Nature. 2019 Jan;565(7739):366-371
pubmed: 30598548
Cancer Cell. 2021 May 10;39(5):708-724.e11
pubmed: 33798472
Nature. 2015 Jun 18;522(7556):345-348
pubmed: 25822788
Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20717-22
pubmed: 24297924
EMBO Mol Med. 2017 May;9(5):672-686
pubmed: 28341702
Signal Transduct Target Ther. 2020 Mar 12;5(1):28
pubmed: 32296047
J Vis Exp. 2014 Sep 27;(91):51677
pubmed: 25285458
Nature. 2017 Nov 2;551(7678):110-114
pubmed: 29072292
Nature. 2011 Jun 08;475(7355):222-5
pubmed: 21654748
J Exp Med. 2013 May 6;210(5):917-31
pubmed: 23589566
Clin Immunol. 2013 Apr;147(1):38-39
pubmed: 23501837
Immunity. 2013 Oct 17;39(4):782-95
pubmed: 24138885
Hepatology. 2011 Sep 2;54(3):900-9
pubmed: 21674558
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
J Clin Invest. 2015 Jun;125(6):2317-34
pubmed: 25915587
J Biol Chem. 2012 Mar 16;287(12):8816-29
pubmed: 22294696
J Immunol. 2017 Dec 15;199(12):4078-4090
pubmed: 29109123
Sci Immunol. 2019 Apr 5;4(34):
pubmed: 30952804
Proc Natl Acad Sci U S A. 2017 Dec 5;114(49):12994-12999
pubmed: 29150554
Immunity. 2016 Oct 18;45(4):889-902
pubmed: 27692609
Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5126-31
pubmed: 15795373
Immunity. 2011 Apr 22;34(4):554-65
pubmed: 21511184
Nature. 2011 Jul 17;475(7357):514-8
pubmed: 21765430
Cancer Discov. 2020 Jan;10(1):124-141
pubmed: 31826876